DongaST requested permission of superbacteria-targeted antibiotics

On August 29th, DongaST submitted new drug application to the Ministry of Food and Drug Safety for releasing SIVEXTRO in domestic market. SIVEXTRO(main component: Tedizolid Phosphate) is Super Bacteria-targeted antibiotics, for the first time, which is approved as a self-developed drug by U.S. FDA.

This new drug application includes global clinical trial data and bridge clinical trial results ...